S100A7 and breast carcinoma: The variance of inhibitory effects by S100A7 knockdown among breast cancer cells indicated that S100A7 may interact with several downstream proteins, such as c-Jun activation domain-binding protein 1 or Ran-binding protein M, to regulate carcinoma cell proliferation [44–46].